Items where Author is "Barzaghi, P."

2009

Erb, M. and Meinen, S. and Barzaghi, P. and Sumanovski, L. T. and Courdier-Fruh, I. and Ruegg, M. A. and Meier, T.. (2009) Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-α2 deficiency. Journal of pharmacology and experimental therapeutics, 331 (3). pp. 787-795.

2007

Meinen, S. and Barzaghi, P. and Lin, S. and Lochmuller, H. and Ruegg, M. A.. (2007) Linker molecules between laminins and dystroglycan ameliorate laminin-alpha2-deficient muscular dystrophy at all disease stages. The Journal of cell biology, Vol. 176, H. 7. pp. 979-993.

2005

Smirnov, S. P. and Barzaghi, P. and McKee, K. K. and Ruegg, M. A. and Yurchenco, P. D.. (2005) Conjugation of LG domains of agrins and perlecan to polymerizing laminin-2 promotes acetylcholine receptor clustering. Journal of Biological Chemistry, 280 (50). pp. 41449-41457.

Bentzinger, C. F. and Barzaghi, P. and Lin, S. and Ruegg, M. A.. (2005) Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice. FASEB Journal, 19 (8). pp. 934-942.

2004

Kong, X. C. and Barzaghi, P. and Ruegg, M. A.. (2004) Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference. EMBO reports, Vol. 5, H. 2. pp. 183-188.

2003

Eusebio, A. and Oliveri, F. and Barzaghi, P. and Ruegg, M. A.. (2003) Expression of mouse agrin in normal, denervated and dystrophic muscle. Neuromuscular Disorders, Vol. 13, H. 5. pp. 408-415.

2001

Moll, J. and Barzaghi, P. and Lin, S. and Bezakova, G. and Lochmuller, H. and Engvall, E. and Muller, U. and Ruegg, M. A.. (2001) An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. Nature, 413 (6853). pp. 302-307.